These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid. Rudolph G; Kloeters-Plachky P; Rost D; Stiehl A Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):487-91. PubMed ID: 17489059 [TBL] [Abstract][Full Text] [Related]
3. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584 [TBL] [Abstract][Full Text] [Related]
4. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. Jesudian AB; Jacobson IM Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124 [TBL] [Abstract][Full Text] [Related]
5. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. Wolf JM; Rybicki LA; Lashner BA Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486 [TBL] [Abstract][Full Text] [Related]
6. Cholangiocarcionoma and primary sclerosing cholangitis: the answer lies within. Shah RJ Gastrointest Endosc; 2014 May; 79(5):780-2. PubMed ID: 24721627 [No Abstract] [Full Text] [Related]
8. Is a raised CA 19-9 level diagnostic for a cholangiocarcinoma in patients with no history of sclerosing cholangitis ? John AR; Haghighi KS; Taniere P; Esmat ME; Tan YM; Bramhall SR Dig Surg; 2006; 23(5-6):319-24. PubMed ID: 17170527 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis. Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687 [TBL] [Abstract][Full Text] [Related]
10. Early detection and treatment of cholangiocarcinoma. Gores GJ Liver Transpl; 2000 Nov; 6(6 Suppl 2):S30-4. PubMed ID: 11084082 [TBL] [Abstract][Full Text] [Related]
11. Impact of dominant stenoses on the serum level of the tumor marker CA19-9 in patients with primary sclerosing cholangitis. Petersen-Benz C; Stiehl A Z Gastroenterol; 2005 Jun; 43(6):587-90. PubMed ID: 15986288 [TBL] [Abstract][Full Text] [Related]
12. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Hultcrantz R; Olsson R; Danielsson A; Järnerot G; Lööf L; Ryden BO; Wahren B; Broomé U J Hepatol; 1999 Apr; 30(4):669-73. PubMed ID: 10207809 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Lindberg B; Arnelo U; Bergquist A; Thörne A; Hjerpe A; Granqvist S; Hansson LO; Tribukait B; Persson B; Broomé U Endoscopy; 2002 Nov; 34(11):909-16. PubMed ID: 12430077 [TBL] [Abstract][Full Text] [Related]
14. Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis. Hilscher M; Enders FB; Carey EJ; Lindor KD; Tabibian JH Ann Hepatol; 2016; 15(2):246-53. PubMed ID: 26845602 [TBL] [Abstract][Full Text] [Related]
15. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 11-2003. A 14-year-old boy with ulcerative colitis, primary sclerosing cholangitis, and partial duodenal obstruction. Ross AM; Anupindi SA; Balis UJ N Engl J Med; 2003 Apr; 348(15):1464-76. PubMed ID: 12686704 [No Abstract] [Full Text] [Related]
16. Primary sclerosing cholangitis and malignancy. Boberg KM; Lind GE Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):753-64. PubMed ID: 22117640 [TBL] [Abstract][Full Text] [Related]
17. Cholangioscopy to screen for cholangiocarcinoma in primary sclerosing cholangitis. Caldwell SH; Bickston SJ Liver Transpl; 2001 Apr; 7(4):380. PubMed ID: 11303302 [No Abstract] [Full Text] [Related]
18. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130 [TBL] [Abstract][Full Text] [Related]
19. Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. Moreno Luna LE; Gores GJ Liver Transpl; 2006 Nov; 12(11 Suppl 2):S15-9. PubMed ID: 17051561 [No Abstract] [Full Text] [Related]
20. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen? de Groen PC Hepatology; 2000 Jan; 31(1):247-8. PubMed ID: 10613754 [No Abstract] [Full Text] [Related] [Next] [New Search]